JPMorgan Chase & Co’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.82M | Sell |
1,032,262
-1,082,447
| -51% | -$5.06M | ﹤0.01% | 2738 |
|
|
2025
Q1 | $11.6M | Buy |
2,114,709
+1,071,268
| +103% | +$5.88M | ﹤0.01% | 2077 |
|
|
2024
Q4 | $3.54M | Buy |
1,043,441
+651,481
| +166% | +$2.21M | ﹤0.01% | 3015 |
|
|
2024
Q3 | $1.12M | Buy |
391,960
+67,557
| +21% | +$193K | ﹤0.01% | 3585 |
|
|
2024
Q2 | $730K | Sell |
324,403
-49,952
| -13% | -$112K | ﹤0.01% | 3676 |
|
|
2024
Q1 | $827K | Buy |
374,355
+51,919
| +16% | +$115K | ﹤0.01% | 3680 |
|
|
2023
Q4 | $758K | Buy |
322,436
+205,480
| +176% | +$483K | ﹤0.01% | 3688 |
|
|
2023
Q3 | $218K | Sell |
116,956
-185,400
| -61% | -$345K | ﹤0.01% | 4190 |
|
|
2023
Q2 | $792K | Sell |
302,356
-463,935
| -61% | -$1.22M | ﹤0.01% | 3556 |
|
|
2023
Q1 | $1.25M | Buy |
766,291
+671,873
| +712% | +$1.1M | ﹤0.01% | 3311 |
|
|
2022
Q4 | $126K | Buy |
94,418
+10,096
| +12% | +$13.5K | ﹤0.01% | 4405 |
|
|
2022
Q3 | $132K | Buy |
84,322
+4,712
| +6% | +$7.38K | ﹤0.01% | 4353 |
|
|
2022
Q2 | $123K | Buy |
79,610
+60,955
| +327% | +$94.2K | ﹤0.01% | 4548 |
|
|
2022
Q1 | $48K | Buy |
18,655
+5,398
| +41% | +$13.9K | ﹤0.01% | 5029 |
|
|
2021
Q4 | $39K | Buy |
13,257
+8,629
| +186% | +$25.4K | ﹤0.01% | 5152 |
|
|
2021
Q3 | $11K | Buy |
4,628
+1,509
| +48% | +$3.59K | ﹤0.01% | 5231 |
|
|
2021
Q2 | $13K | Sell |
3,119
-14,115
| -82% | -$58.8K | ﹤0.01% | 5186 |
|
|
2021
Q1 | $78K | Sell |
17,234
-3,115
| -15% | -$14.1K | ﹤0.01% | 4711 |
|
|
2020
Q4 | $100K | Buy |
20,349
+3,215
| +19% | +$15.8K | ﹤0.01% | 4302 |
|
|
2020
Q3 | $100K | Sell |
17,134
-2,639,449
| -99% | -$15.4M | ﹤0.01% | 4051 |
|
|
2020
Q2 | $7.07M | Buy |
2,656,583
+2,648,064
| +31,084% | +$7.04M | ﹤0.01% | 1929 |
|
|
2020
Q1 | $17K | Sell |
8,519
-222
| -3% | -$443 | ﹤0.01% | 4390 |
|
|
2019
Q4 | $62K | Hold |
8,741
| – | – | ﹤0.01% | 4171 |
|
|
2019
Q3 | $86K | Buy |
8,741
+1,417
| +19% | +$13.9K | ﹤0.01% | 4049 |
|
|
2019
Q2 | $79K | Sell |
7,324
-2,119
| -22% | -$22.9K | ﹤0.01% | 4097 |
|
|
2019
Q1 | $95K | Buy |
9,443
+7,734
| +453% | +$77.8K | ﹤0.01% | 4018 |
|
|
2018
Q4 | $29K | Buy |
1,709
+177
| +12% | +$3K | ﹤0.01% | 4423 |
|
|
2018
Q3 | $27K | Buy |
+1,532
| New | +$27K | ﹤0.01% | 4520 |
|